CUAM CSI Precision Medicine Theme Index Initiated Securities Investment Fund (LOF) (abbreviation: CUAM CSI Precision Medicine Index (LOF) A, code 501005) announced its latest net value on March 27, up 3.23%.
CUAM CSI Precision Medicine Index (LOF) A was established on 21 January 2016, and the performance comparison benchmark is the yield of the CSI Precision Medicine Theme Index ×95% + the bank RMB demand deposit interest rate (after tax) ×5%. The fund has returned -12.12% since its inception, 16.91% this year, -0.18% over the past month, 15.49% over the past year, and -32.89% over the last three years. In the past year, the fund ranked 1872/3480 in its peer group.
The fund manager is Wu Zhenxiang. Wu Zhenxiang has managed (or intends to manage) the fund since December 17, 2015, with a return of -12.12% during his tenure.
According to the latest periodic report, the fund's top 10 heavy stocks are as follows:
| stock symbol | ,stock name | ,position ratio | , number of shares held (shares). | Market value of the position (RMB). |
| 300760 | Mindray Medical | 5.11% | 222147 | 56.6475 million |
| 688235 | BeiGene | 4.96% | 341793 | 55.0355 million |
| 600196 | Fosun Pharma | 4.92% | 2194466 | 54.5325 million |
| 603259 | WuXi AppTec | 4.86% | 978804 | 53.8734 million |
| 600276 | Hengrui | Pharmaceutical4.84% | 1169056 | 53,659,70688,180 |
| , | Junshi Biosciences | 4.68%, | 1899327 | 51,908,600 |
| 002821 | Gloria Ying | 4.59% | 668960 | 50.9012 million |
| 300759 | Pharmaron | 4.52% | 1950514 | 50.1282 million |
| 300558 | Betta Pharmaceuticals | 4.50% | 925296 | 49.9012 million |
| 688578 | Allist | 4.48% | 829288 | 49.6744 million |
Ticker Name
Percentage Change
Inclusion Date
